Burden of Infectious Diseases Compounded by the Emergence of Newer Diseases, Rising Emphasis on Immunization & Increasing Vaccine R&D Efforts to Drive the Global Human Vaccines Market
Burden of infectious diseases compounded by the emergence of newer diseases, favorable governmental policies, increasing initiatives both at the government and private levels for extending immunization worldwide, and rising investments in research and development of new vaccines are poised to drive the global market for Human Vaccines to reach US$42 billion by 2024 . The global market for human vaccines is expected to witness rapid growth, driven by a number of factors, including growing incidence of infectious diseases, favorable governmental policies, increasing initiatives both at the government and private levels for extending immunization worldwide, and increasing investment by companies for research and development of new vaccines. Emergence of newer diseases also constitutes one of the key drivers propelling market growth. Companies are therefore trying to develop new and more effective vaccines against emerging infections, such as dengue, Ebola, and Zika. The market for h...